We provide recommendation to complement the prevalent
expert consensus on Xtant Medical Holdings. Our dynamic recommendation engine utilizes a multidimensional algorithm to analyze the firm's potential to grow using all technical and fundamental data available at the time.
Typically, a company's
financial statements are the reports that show the
financial position of the company. There are three main documents that fall into the category of financial statements. These documents include Xtant Medical income statement, its balance sheet, and the statement of cash flows. Potential Xtant Medical investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Xtant Medical investors may use each financial statement separately, they are all related. The changes in Xtant Medical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Xtant Medical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our
technical analysis and
fundamental analysis pages.
The goal of Xtant Medical
fundamental analysis is to do accurate financial forecasts. There are several possible objectives to fundamental analysis, such as projecting of Xtant Medical performance into the future periods or doing a reasonable stock valuation. The intrinsic value of Xtant Medical shares is the value that is considered the true value of the share. If
the intrinsic value of Xtant is higher than its market price, buying is generally recommended. If it is equal to the market price, it is recommended to hold; and if it is less than the market price, then one should sell all shares Xtant Medical. Please read more on our
fundamental analysis page.
Watch out for price decline
Please consider monitoring Xtant Medical on a daily basis if you are holding a position in it. Xtant Medical is trading at a penny-stock level, and the possibility of delisting is much higher compared to other stocks. However, just because the stock is trading under one dollar, does not mean it will be marked for deletion.
Most exchanges require public instruments, such as Xtant Medical stock to be traded above the $1 level to remain listed. If Xtant Medical stock price falls below $1 for 30 consecutive trading days, the exchange can delist it. Once the company reaches this point, they will be sent an initial price violation notice directly from an exchange.
How effective is Xtant Medical in utilizing its assets?
Xtant Medical Holdings reports assets on its Balance Sheet. It represents the amount of Xtant resources that either has an existing economic value or will provide some form of benefits in the future. By effectively utilizing its assets, Xtant Medical aims to generate revenue, control costs, drive operational efficiency, and enhance profitability. Optimizing asset utilization helps maximize shareholder value and maintain a competitive position in the Health Care Equipment & Supplies space. To get a better handle on how balance sheet or income statements item affect Xtant volatility, please check the breakdown of all its
fundamentals.
Are Xtant Medical Earnings Expected to grow?
The
future earnings power of Xtant Medical involves the interaction of many company-specific, industry, and economic forces. Earnings estimates embody investors' opinions of Xtant Medical factors such as sales growth, product demand, competitive industry environment, profit margins, and cost controls. Xtant Medical
stock prices adjust as these expectations change or are proven wrong. The main thing to remember is that equities with high expected earnings growth tend to underperform the market because it is usually difficult to meet the market's high expectations. Companies with low earnings expectations tend to do better than expected. Please use our latest analysis of Xtant
expected earnings.
Xtant Medical Gross Profit
Xtant Medical Gross Profit growth is one of the most critical measures in evaluating the company. The Gross Profit growth rate is calculated simply by comparing Xtant Medical previous period's values with its current period's values. Each time period you're measuring should be of equal lengths the increase or decrease, in a company's Gross Profit between two periods. Here we show Xtant Medical Gross Profit growth over the last 10 years. Please check Xtant Medical's
gross profit and other
fundamental indicators for more details.
Breaking it down a bit more
Institutional investors typically avoid acquiring a high percentage of Xtant Medical stocks because performing such an act may violate securities laws. They are usually not investing their own money, but rather making investments on behalf of their clients. Let's take a look at how the ownership of Xtant is distributed among investors.
Ownership Allocation
Xtant Medical Holdings owns a total of 76.86 Million outstanding shares. The majority of Xtant Medical
outstanding shares are owned by
institutional investors. These institutions are usually referred to as non-private investors looking to purchase positions in Xtant Medical Holdings to benefit from reduced commissions. Consequently, other corporate entities are subject to a different set of regulations than regular investors in Xtant Medical Holdings. Please pay attention to any change in the institutional holdings of Xtant Medical Holdings as this could imply that something significant has changed or about to change at the company. Remember, it does not matter who owns the company or if the company is currently
losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
| Retail Investors | 1.78 |
| Insiders | 2.34 |
| Institutions | 95.88 |
Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Xtant Medical has an asset utilization ratio of 39.91 percent. This implies that the company is making $0.4 for each dollar of assets. An increasing asset utilization means that Xtant Medical Holdings is more efficient with each dollar of assets it utilizes for everyday operations.
| Current Assets47.6 M | Assets Non Current93.2 M | Goodwill79.4 M |
| Current Assets | 47.57 Million | 21.6 |
| Assets Non Current | 93.21 Million | 42.33 |
| Goodwill | 79.4 Million | 36.06 |
Our take on today Xtant Medical gain
The kurtosis is down to 0.84 as of today. Xtant Medical Holdings exhibits above-average semi-deviation for your current time horizon. We encourage investors to investigate Xtant Medical Holdings individually to make sure intended market timing strategies and available technical indicagtors are consistent with their estimates about Xtant Medical future systematic risk. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Xtant Medical's stock risk against market volatility during both bullying and bearish trends. The higher level of volatility that comes with bear markets can directly impact Xtant Medical's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.
The Current Takeaway on Xtant Medical Investment
Whereas many other companies under the medical devices industry are still a bit expensive, Xtant Medical may offer a potential longer-term growth to private investors. With a less-than optimistic outlook for your 30 days horizon, it may be a good time to short some or all of your Xtant Medical holdings as it seems the potential growth was already fully factored into the current price. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to Xtant Medical.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectEditorial Staff
Ellen Johnson is a Member of Macroaxis Editorial Board. Ellen covers public companies in North America, focusing primarily on valuation and volatility. Six years of experience in predictive investment analytics and risk management.
View Profile This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Ellen Johnson do not own shares of Xtant Medical Holdings. Please refer to our
Terms of Use for any information regarding our disclosure principles.
Would you like to provide feedback on the content of this article?
You can get in touch with us directly or send us a quick note via email to
editors@macroaxis.com